User profiles for V. V. Barve

Vijay Barve

Digitization Project Manager, Natural History Museum of LA
Verified email at nhm.org
Cited by 3788

Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease

S Khan, KH Barve, MS Kumar - Current neuropharmacology, 2020 - ingentaconnect.com
Background: The only conclusive way to diagnose Alzheimer’s is to carry out brain autopsy
of the patient’s brain tissue and ascertain whether the subject had Alzheimer’s or any other …

Cytokines in alcoholic liver disease

CJ McClain, S Barve, I Deaciuc… - Seminars in liver …, 1999 - thieme-connect.com
Cytokines are low-molecular-weight mediators of cellular communication produced by multiple
cell types in the liver, with the Kupffer cell critically important. Inflammatory cytokines such …

Molecular mechanisms of acrolein toxicity: relevance to human disease

…, S Barve, C McClain, S Joshi-Barve - Toxicological …, 2015 - academic.oup.com
Acrolein, a highly reactive unsaturated aldehyde, is a ubiquitous environmental pollutant
and its potential as a serious environmental health threat is beginning to be recognized. …

The crucial role of the accessible area in ecological niche modeling and species distribution modeling

N Barve, V Barve, A Jiménez-Valverde… - Ecological …, 2011 - Elsevier
Using known occurrences of species and correlational modeling approaches has become a
common paradigm in broad-scale ecology and biogeography, yet important aspects of the …

[PDF][PDF] Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant

…, JE Lemieux, JB Munro, A Rafique, A Barve… - Cell, 2020 - cell.com
The SARS-CoV-2 spike (S) protein variant D614G supplanted the ancestral virus worldwide,
reaching near fixation in a matter of months. Here we show that D614G was more infectious …

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

…, L Bazhenova, JC Krauss, YK Chae, M Barve… - The Lancet …, 2020 - thelancet.com
Background Entrectinib is a potent inhibitor of tropomyosin receptor kinase (TRK) A, B, and
C, which has been shown to have anti-tumour activity against NTRK gene fusion-positive …

[HTML][HTML] Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C

…, J Weiss, MS Pelster, AI Spira, M Barve… - … England Journal of …, 2023 - Mass Medical Soc
Background Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein, has
shown clinical activity in pretreated patients with several tumor types, including colorectal …

Constraints on interpretation of ecological niche models by limited environmental ranges on calibration areas

…, LP Campbell, LL Dornak, EE Saupe, N Barve… - Ecological …, 2013 - Elsevier
Correlational models of species’ ecological niches are commonly used to transfer model
rules onto other sets of conditions to evaluate species’ distributional potential. As with any …

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

…, S Sundaram, JB Cohen, IW Flinn, CS Tam, MA Barve… - The Lancet, 2021 - thelancet.com
Background Covalent Bruton's tyrosine kinase (BTK) inhibitors are efficacious in multiple B-cell
malignancies, but patients discontinue these agents due to resistance and intolerance. …

[HTML][HTML] kuenm: an R package for detailed development of ecological niche models using Maxent

ME Cobos, AT Peterson, N Barve, L Osorio-Olvera - PeerJ, 2019 - peerj.com
Background Ecological niche modeling is a set of analytical tools with applications in diverse
disciplines, yet creating these models rigorously is now a challenging task. The calibration …